July 1, 2022
The Ministry of Health, Labor and Welfare (MHLW) said on June 30 that the new drug review pathway in the Philippines can now be abridged significantly by submitting an assessment report by Japan’s Pharmaceuticals and Medical Devices Agency (PMDA). Japan...read more